Gausemycins A,B – cyclic lipoglycopeptides from Streptomyces sp.
We report a novel family of natural lipoglycopeptides produced by Streptomyces sp. INA-Ac-5812. Two major components of the mixture, named gausemycins A and B, were isolated, and their structures were elucidated. The compounds are cyclic peptides with a unique peptide core and several remarkable structural features, including unusual positions of D-amino acids, lack of the Ca 2+ -binding Asp-X-Asp-Gly (DXDG) motif, tyrosine glycosylation with arabinose, presence of 2-amino-4-hydroxy-4-phenylbutyric acid (Ahpb) and chlorinated kynurenine (ClKyn), N -acylation of the ornithine side chain. Gausemycins have pronounced activity against Gram-positive bacteria. Mechanistic studies highlight significant differences compared to known glyco- and lipopeptides. Gausemycins exhibit only slight Ca 2+ -dependence of activity and induce no pore formation at low concentrations. Moreover, there is no detectable accumulation of cell wall biosynthesis precursors under treatment with gausemycins.
: 34009717
Список научных проектов, где отмечена публикация
- 20-33-70215. . Сommercial.
- 20-54-53014. . Сommercial.
- 21-47-04405. . Сommercial.
- Structural biology of membrane proteins for the development of new drugs and diagnostics (June 1, 2019 December 31, 2022). . Grant, RSF.


: